Conference Coverage

ESBL-B before colorectal surgery ups risk of surgical site infection

Publish date: May 17, 2018

 

REPORTING FROM ECCMID 2018

Dr. Yehuda Carmeli of Tel Aviv Medical Center. Michele G Sullivan/MDedge News

Dr. Yehuda Carmeli

The study’s primary outcome was surgical site infection, which was assessed regularly during the hospital stay, at discharge, and by clinic visit or telephone call 30 days after discharge. The secondary outcomes were deep space surgical site infections and infections caused specifically by ESBL-B. ESBL-B was significantly associated with both surgical site infection (OR 2.25) and deep space infection (OR 2.25).

A multivariate analysis controlled for age, cardiovascular disease, indication for surgery, and whether the procedure included a rectal resection, retention of drain at the surgical site, or stoma. The model also controlled for National Nosocomial Infection Surveillance score, a three-point scale that estimates surgical infection risk. Among this cohort, 48% were at low risk, 43% at moderate risk, and 10% at high risk.

Dr. Carmeli made no financial disclosures.

SOURCE: Carmeli et al, ECCMID 2018, Oral Abstract O1133.

Pages

Recommended Reading

Reported penicillin allergies hike inpatient costs
MDedge Internal Medicine
Preoperative penicillin allergy tests could decrease SSI
MDedge Internal Medicine
Prehospital antibiotics improved some aspects of sepsis care
MDedge Internal Medicine
Bile spillage during lap cholecystectomy comes with a price
MDedge Internal Medicine
Complication rates rise after decline in uterine fibroid morcellation
MDedge Internal Medicine
Robotic approach falls short for sleeve gastrectomy
MDedge Internal Medicine
Piperacillin-tazobactam tripled risk of death for patients with cephalosporin-resistant septicemia
MDedge Internal Medicine
ESBL-resistant bacteria spread in hospital despite strict contact precautions
MDedge Internal Medicine